|
US6207454B1
(en)
|
1989-10-16 |
2001-03-27 |
Amgen Inc. |
Method for enhancing the effciency of gene transfer with stem cell factor (SCF) polypeptide
|
|
US6852313B1
(en)
|
1989-10-16 |
2005-02-08 |
Amgen Inc. |
Method of stimulating growth of melanocyte cells by administering stem cell factor
|
|
US6248319B1
(en)
|
1989-10-16 |
2001-06-19 |
Krisztina M. Zsebo |
Method for increasing hematopoietic progenitor cells by stem cell factor polypeptides
|
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
|
US5581476A
(en)
|
1993-01-28 |
1996-12-03 |
Amgen Inc. |
Computer-based methods and articles of manufacture for preparing G-CSF analogs
|
|
MXPA01005564A
(es)
*
|
1998-12-04 |
2003-07-14 |
Naval Medical Res Ct |
Celulas del endotelio cerebral humano en medio de crecimiento y metodo para expansion de celulas de tallo de medula osea cd34+cd38-nativas.
|
|
EP1228200A1
(en)
*
|
1999-10-27 |
2002-08-07 |
California Institute Of Technology |
Production of functional hybrid genes and proteins
|
|
US6346247B1
(en)
|
1999-10-28 |
2002-02-12 |
Promega Corporation |
Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies
|
|
GB0024550D0
(enExample)
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
|
MXPA03005014A
(es)
|
2000-12-06 |
2004-09-10 |
Robert J Hariri |
Metodo para recolectar celulas madres de la placenta.
|
|
US7311905B2
(en)
|
2002-02-13 |
2007-12-25 |
Anthrogenesis Corporation |
Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells
|
|
AU2002251935B2
(en)
|
2001-02-14 |
2007-11-29 |
Celularity Inc. |
Post-partum mammalian placenta, its use and placental stem cells therefrom
|
|
KR100961859B1
(ko)
|
2001-07-11 |
2010-06-09 |
맥시겐 홀딩스 엘티디 |
지-씨에스에프 접합체
|
|
AU2003298775B2
(en)
|
2002-11-26 |
2008-07-17 |
Anthrogenesis Corporation |
Cytotherapeutics, cytotherapeutic units and methods for treatments using them
|
|
KR20080027291A
(ko)
|
2005-06-01 |
2008-03-26 |
맥시겐 홀딩스 엘티디 |
피이지화된 지-씨에스에프 폴리펩타이드 및 그 제조방법
|
|
EP1957633B1
(en)
|
2005-10-13 |
2013-12-18 |
Anthrogenesis Corporation |
Immunomodulation using placental stem cells
|
|
AU2006332679A1
(en)
|
2005-12-29 |
2007-07-12 |
Anthrogenesis Corporation |
Co-culture of placental stem cells and stem cells from a second source
|
|
KR20180105266A
(ko)
|
2005-12-29 |
2018-09-27 |
안트로제네시스 코포레이션 |
태반 줄기 세포 집단
|
|
CN103356710A
(zh)
|
2007-02-12 |
2013-10-23 |
人类起源公司 |
利用胎盘干细胞治疗炎性疾病
|
|
US9200253B1
(en)
|
2007-08-06 |
2015-12-01 |
Anthrogenesis Corporation |
Method of producing erythrocytes
|
|
EP2203176B1
(en)
|
2007-09-28 |
2014-11-26 |
Anthrogenesis Corporation |
Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells
|
|
NZ591292A
(en)
|
2008-08-20 |
2012-10-26 |
Anthrogenesis Corp |
Improved cell composition and methods of making the same
|
|
CA2734237C
(en)
|
2008-08-20 |
2019-07-02 |
Anthrogenesis Corporation |
Treatment of stroke using isolated placental cells
|
|
SI2331109T1
(sl)
|
2008-08-22 |
2013-10-30 |
Anthrogenesis Corporation |
Postopki in sestavki za zdravljenje okvar kosti s populacijami placentarnih celic
|
|
WO2010059828A1
(en)
|
2008-11-19 |
2010-05-27 |
Anthrogenesis Corporation |
Amnion derived adherent cells
|
|
EP2449095A1
(en)
|
2009-07-02 |
2012-05-09 |
Anthrogenesis Corporation |
Method of producing erythrocytes without feeder cells
|
|
DK2454363T3
(da)
*
|
2009-07-13 |
2020-10-12 |
Biogencell Ltd |
Fremgangsmåde til anvendelse af celler, der leder til specifik stam-/progenitorcelleaktivering og -differentiering
|
|
CA2787992A1
(en)
|
2010-01-26 |
2011-08-04 |
Anthrogenesis Corporation |
Treatment of bone-related cancers using placental stem cells
|
|
PL2556145T3
(pl)
|
2010-04-07 |
2017-02-28 |
Anthrogenesis Corporation |
Angiogeneza z zastosowaniem łożyskowych komórek macierzystych
|
|
KR20130092394A
(ko)
|
2010-04-08 |
2013-08-20 |
안트로제네시스 코포레이션 |
태반 줄기 세포를 사용한 사르코이드증의 치료
|
|
MX342995B
(es)
|
2010-07-13 |
2016-10-21 |
Anthrogenesis Corp |
Métodos de generar células asesinas naturales.
|
|
US8969315B2
(en)
|
2010-12-31 |
2015-03-03 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
|
DK2714059T3
(en)
|
2011-06-01 |
2019-01-21 |
Celularity Inc |
TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS
|
|
WO2013055476A1
(en)
|
2011-09-09 |
2013-04-18 |
Anthrogenesis Corporation |
Treatment of amyotrophic lateral sclerosis using placental stem cells
|
|
US8956870B2
(en)
|
2012-01-19 |
2015-02-17 |
Biogencell, Ltd. |
Method for using directing cells for specific stem/progenitor cell activation and differentiation
|
|
US9156897B2
(en)
|
2012-06-08 |
2015-10-13 |
Alkermes, Inc. |
Fusion polypeptides comprising an active protein linked to a mucin-domain polypeptide
|
|
EP3622960A1
(en)
|
2013-02-05 |
2020-03-18 |
Celularity, Inc. |
Natural killer cells from placenta
|
|
WO2023145860A1
(ja)
*
|
2022-01-27 |
2023-08-03 |
味の素株式会社 |
Ｓｃｆ受容体結合ペプチド
|